MeMAGEN: A Phase IIa/IIb open‐label trial of memantine testing safety and tolerability in sickle cell patients

Documenti analoghi

• Examining the secret life of the spleen in sickle cell disease
  di: Adama Ladu, et al.
  Pubblicazione: (2025)
• News on sickle cell disease: Heme‐driven disordered erythropoiesis
  di: Francesca Vinchi
  Pubblicazione: (2024)
• Inflammatory pathways and anti‐inflammatory therapies in sickle cell disease
  di: Karina Tozatto‐Maio, et al.
  Pubblicazione: (2024)
• New approaches in gene therapy for sickle cell disease, moving in vivo
  di: David G. Kent
  Pubblicazione: (2024)
• Can health inequalities in sickle cell disease be addressed through novel therapies?
  di: Stephen P. Hibbs, et al.
  Pubblicazione: (2025)